Jaglix 100 mg filmom obložene tablete
| Name | Jaglix 100 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-087172599 |
| Active Substance | sitagliptinklorid hidrat |
| Composition | jedna tableta sadrži sitagliptinklorid hidrat što odgovara 100 mg sitagliptina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Mylan Hungary Kft, Komárom, Mađarska Medis International A.S., Bolatice, Češka McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin, Dublin, Irska |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 02.11.2022 |
| MA Period of Validity | 23.04.2026 |
| Classification Number | UP/I-530-09/19-01/284 |
| Registration Number | 381-12-01/154-22-14 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BH01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
